chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I woke up during the night with nauseu.  I did not vomit.  My oral temperature at 6am (approximately 12 hours after the shot) was 99.45, which is about two degrees higher than my normal waking temperature for this part of my cycle.  For the remainder of the day, I felt very fatigued, I  experienced both body aches and a strong headache.  At one point, I had a pain in my right shoulder, but I think that was random and unrelated.  At 12:45 p.m., my oral temperature was 100.85.  I took two acetaminophen pills at about 1:00pm.  My oral temperature at 3:45pm was 98.9 and was back to 99.17 at 5:15pm.  From 5:30-7:30 pm, I experiences moderate to severe pain in  my chest (I believe it was probably heartburn, which I have never really experienced in the past).  I found temporary relief by moving around.  The pain made me dry heave at one point because it made me nauseous, but I did not vomit.  I took one acetaminophen pill at about 6:15pm.  My oral temperature was 99.45 at 7:30pm.    I woke up at about 4:15 am again with the chest and abdominal pain.  My oral temperature at that time was 98.34.  I paced for about 30 minutes and the pain went away.  When I woke up at 7:00 am on 11/19 (about 36 hours after the shot), by temperature was 98.04 and I have not experienced any symptoms since then.
Received the Moderna Covid-19 vaccine. My psoriasis was over 95% clear (no medication taken) up to the time I received the vaccine, it is now on about 25 to 30 percent of my body, mostly on my buttocks and legs. I know of someone else who has psoriasis and her psoriasis got much worse after the vaccine also. I noticed it getting worse after my second dose. Not sure I will be getting the booster, can't afford for it to get worse.
This spontaneous report was received from a medical assistant concerning multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported.  On 31-JAN-2017, the patients were vaccinated with improperly stored doses of VAQTA lot # M033611, expiration date: 02-MAR-2018, as prophylaxis (Strength, dose and route of administration were not reported), which experienced a temperature excursion between 46 and 77 Fahrenheit degrees for 1 hour. No previous temperature excursions were reported. Digital data logger was involved. No adverse effects were reported. A product quality complaint was not involved. This is one of two reports received from the same patient. Additional information has been requested. Sender's Comments: US-009507513-1702USA004739.
patient stated not feeling well and did not eat. verbal resp distress tongue edema. 1335 c/o heartburn ER visit offered and accepted
This spontaneous report was received from a Pharmacist, concerning a patient of unknown age and gender. The patient's pertinent medical history, concomitant medication and drug reactions or allergies were not reported. On an unknown date, the patient was vaccinated with a dose of M-M-R II, via intramuscular route of administration, instead of subcutaneous, for prophylaxis (dose, anatomical location, lot number and expiration date were not reported) (Incorrect route of drug administration). No adverse effects were reported. No product quality complaint (PQC) was involved.  Follow-up information was received on 03-OCT-2018. On 03-OCT-2018, a phone call was made to the pharmacist. A pharmacy tech, who was there at the time the administration error happened, answered the call and she was able to provide that it happened with only one patient.  Follow-up information received from Pharmacist on 04-OCT-2018. It was confirmed that the patient was female, who was approximately between 40 to 60 years of age. It was reported that the administration error occurred at the end of May 2018, and it was the pharmacist first day back to work at the pharmacy after being on maternity leave. The pharmacist had asked her co-worker about the correct route, and she relied on what her coworker said. The pharmacist didn't realize that it was given incorrectly (given intramuscular instead of subcutaneously) until she contacted the company. The pharmacist "notified the patient after that about the incorrect route but the patient said she was fine, the patient had no complaints" or adverse reactions. A request was made for lot and expiration date information but she thought it might had been "returned and had since expired" since May 2018. The pharmacist was not able to provide any additional information.  This case was previously considered non-valid, but upon receipt of follow-up it was determined that the case is now valid as the patient identifiers were provided.
about 5 minutes after administration of vaccines his eyes rolled back in his head, he got pale and lost consciousness. He fell to the ground. The whole episode lasted less than one minute but was frightening.  He hurt his right knee because the the way he fell (crumpled)but it was more of a soft tissue injury.  We watched him for 30 minutes in the office after and he was fine.
temperature excursion; Initial information received on 18-Feb-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a patient with unknown demographics who had temperature excursion while receiving vaccines MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] and IPV (VERO) [IPOL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE with unknown dose, lot number, route, administration site for immunization.  On an unknown date, the patient received a  dose of suspect IPV (VERO)with unknown dose lot T1D482M via unknown route, administration site for immunization. 1 other doses were administered on unknown dates for suspect IPV (VERO).  On an unknown date the patient had temperature excursion (product temperature excursion issue) (unknown latency) following the administration of IPV (VERO) and (unknown latency) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event (temperature excursion).  At time of reporting, the outcome was Unknown for the event temperature excursion.   Additional information was received on 18-Feb-2022 from Other health care professional: Case updated from Non-case to valid case.
within 2.5 to 3 hrs after shot patient had difficulty walking, severe pain in lower right back, pain down right leg, constant Nausua and all over itching. after doctor visit on 10/12/07 and 12 hour ER visit on 10/13/07. SEVERE PAIN and symptoms were unmanagable at home so doctor admitted haer to hospital on 10/15/07.1/17/08-records received for DOS 10/15-10/24/07-DC DX: Muscle spasm pain in right flank. Developed right flank pain four days prior to admission. Seen in ED twice.
Hives  and welts  throughout my body for over  a month now.  I my skin reacts when I eat  basically anything.  I get rashes when the weather is hot and/or cold.  My skin is very sensitive with temperature and exposure (i.e Sun, water) .
Patient presented with chest pain initially with exertion on day one of illness (2 days post immunization), but by day 3 of illness (4 days post immunization) with acute onset midsternal chest pain that woke him from sleep.  Pain did not radiate,  he did not have any shortness of breath but pain with deep expiration. EKG performed in the ED showed diffuse ST elevations, and because of this patient underwent left heart catheterization.  Left heart catheterization performed showed normal coronary arteries, left ventricle dysfunction with apical hypokinesis and an estimated ejection fraction of 50%, elevated left ventricular end-diastolic pressure of 20-25 mmHg, and no evidence of aortic stenosis, insufficiency, dissection, aneurysm. . Initial troponin level elevated to 12.4, max troponin level of 31.3. Pediatric cardiology was consulted with recommendations to start ibuprofen 600 mg every 6 hours. An echocardiogram was performed and showed mildly decreased longitudinal strain in the apex and inferior basal segments. Patient currently continued on ibuprofen 600 mg q6h, with improvement of troponin level.
CONTRACTED COVID-19; This spontaneous report received from a patient via a company representative concerned a 71 year old female of an unspecified race and ethnicity. The patient's weight, height, and medical history were not reported. The patient previously received covid-19 vaccine ad26. cov2. s (unspecified manufacturer) (dose number in series: 1) (suspension for injection, route of admin, batch number and expiry were not reported) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis.  It was unknown whether patient had any adverse events following covid-19 vaccine ad26. cov2. s (unspecified manufacturer) (dose number in series: 1). The patient received covid-19 vaccine ad26.cov2.s (dose number in series: 2) (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, after booster dose, the patient contracted covid-19 from one of her relatives (dose number in series 2). The patient had nothing more than a runny nose. She was very pleased with the results of getting the vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of contracted covid-19 was not reported. This report was non-serious. This report was associated with a product quality complaint: 90000248991.
This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), TACHYCARDIA (increased heart rate), ANXIETY (anxiety) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Shortness of breath (Patient used a CPAP machine for shortness of breath (prior to Moderna COVID-19 vaccination)) and Heart rate increased. On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Aug-2021, the patient experienced DYSPNOEA (shortness of breath), TACHYCARDIA (increased heart rate), ANXIETY (anxiety) and CHILLS (chills). At the time of the report, DYSPNOEA (shortness of breath), TACHYCARDIA (increased heart rate), ANXIETY (anxiety) and CHILLS (chills) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment medications were reported.
Exahoustin, fever of 100F , feels worst than when had COVID back on mid October
Patient became extremely lightheaded and nauseous. Loss of energy and light-headedness severe enough for her to have to leave job. These symptoms lasted approximately 24-36 hours.
RECD PRIMARY SMALLPOX ON 10/02/2003 ON DAY 9 10/11/2003 EXPERIENCED SUBSTERNAL CHEST PAIN 5/10 IN INTENSITY. EXPERIENCED CHESTPAIN FOR THREE DAYS BEFORE SEEKING MEDICAL ATTENTION. CHEST XRAY, EKG,TROPONIN LEVEL OBTAINED. TREATED WITH MOTRIN 800MG TID.
Neuropathy; Feel crazy; Irritable; Depression; Feel extremely agitated and unstable; This is a spontaneous report from a contactable consumer (patient). A 21-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on the left arm on 23Apr2021 (10:00) as a single dose, with route of administration unspecified, for COVID-19 immunization. Medical history included type 1 diabetes; peripheral neuropathy; autonomic neuropathy; and clinical depression. The patient was not pregnant at the time of vaccination. Concomitant medications included propranolol, gabapentin, metformin and duloxetine hydrochloride (CYMBALTA). On 23Apr2021 (18:00), the patient had neuropathy; had felt crazy; was irritable; had depression; and had felt extremely agitated and unstable. The outcome of the events was not recovered. The patient had no COVID-19 prior to vaccination, and had not been tested post-vaccination.  Information on lot/batch number was available. Additional information has been requested.
itching all over and that the first one wasn't so bad; couldn't sleep; asthma was worse also; This is a spontaneous report from a contactable consumer (patient). An 81-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: EL892, Expiration date: 31May2021), via an unspecified route of administration on 30Jan2021 (at the age of 81-years-old) as dose 1, single for COVID-19 immunisation. Medical history included diabetes mellitus, cancer twice, asthma, osteoporosis, heart problems, poison ivy (hospitalized), cholesterol, and allergies (about 18 allergies of things that she is allergic to). Concomitant medications included unspecified cholesterol medication. On an unspecified date after the first vaccine, the patient experienced itching all over and that the first one wasn't so bad, couldn't sleep, and asthma was worse also. It was reported that the patient has about 18 allergies of things that she was allergic to; she has dealt with allergies since she had poison ivy and she was hospitalized with it and has dealt with allergies a long time and knew that each time of getting around something or having same medicine or whatever it gets worse. The patient stated that she can get a list of all her allergies from her doctor. She stayed in the house as all around her has been the virus and people in the hospital and she was scared to even go out. She was scared to walk down the street and people have the virus and don't feel it and she doesn't want to get it and people with the virus shouldn't be out. The patient stated that when she took her 1st shot, she had reaction and thought it was because her heart doctor had put on different cholesterol medication and she thought that she was reacting to that a little bit but then it eased off in a couple days. When the virus first came out the patient's doctor wouldn't see her and sent her to the ER, and they checked her thoroughly for the virus and a month later she went to the health department for a check for the virus. It was reported that the patient had some sort of virus for about 3 weeks. The patient's friend told her that if she had a reaction to the shots, she would have to take them again, but her doctor said she would not have to. The patient was concerned about having to repeat the vaccine and wanting that question addressed. The patient was querying if the shots will be as effective if she has taken Benadryl. Treatment with diphenhydramine hydrochloride (BENADRYL) was taken for the events. The events resulted in a physician office visit (consultation with her doctor). The outcome of the events was unknown. The patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: EL9266, Expiration date: 31May2021), via an unspecified route of administration on 21Feb2021 (at the age of 81-years-old) for COVID-19 immunisation  No follow-up attempts are possible. No further information is expected.
Receiving vaccine due to non-immune status and with 3 month old infant. On 4/12 had initial "bump" on face with progression of large number of "bumps" on scalp, neck, chest, back, and arms.  Bumps not fluid-filled, but quite itchy per client.  Injection site edematous, hot to touch and painful - "feels very irritated" per client.
Heat needles sensation recurring in left foot large toe. Arose temporarily and recurred over next 6 hours. Extreme pain which felt like pain of shingles!
pt with macualr -papular rash on chest abdomen, arms,  palm, soles, legs face spared + itching treated with benadryl, hydrocortisone, calamine. He recently had rash, itching and was found to be allergic to multiple grasses and trees.
Rash about 4 hrs after injections. Rash is pruritic, minor cough, no fever. Rash is on his hands, arms, legs, neck and back. Topical HCS 1% bid x 1 week PRN, PO BENADRYL, Calamine lotion, oatmeal baths.
Bad flu symptoms with fever 2 hours after vaccine lasting 48 hours. Chills, fever, vomiting, light sensitivity, headache, body aches, nausea and dizziness. Both doses also resulted in large rash, she is exhibiting hives now 3 days after. Still tired 4 days later, arm is sore and 3 inch rash at injection site.
3 days after receiving the shingle vaccine, left side of neck and face broke out with large whelps and then opened up and sores, itching and burning.
The patient developed a fever shortly after receiving vaccines per mother it was 103.7 taken rectally mother gave her infant son Tylenol which didn't bring it down too much so they took him to the emergency room where his temperature was then noted to be 100.3. The patient was brought in to our clinic again on 9/10/2021 at 4:00 pm to examine him since he still had a temperature of 101.3 per the patients mother with using Tylenol and we noted he had lumps at the injection sites of the Pneumococcal 13 and the pentacle vaccines with some redness at injection sites but no swelling noted. When he arrived at our clinic at 4:00 pm mother noted she gave him another dose of Tylenol at 3:30 Pm and his temperature rectally was 99.7.
Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 38 days before the administration. There were no adverse reactions reported after the administration.
Headache, nausea, tiredness, feeling unwell and injection site pain. Warm to touch injection site, raised lump on left arm.
Vomiting, nausea, chills, fatigue, headache, dizziness, coughing, runny nose, sinus pressure
The patient was waiting in the store for her 15 minute observation period after her 2nd covid vaccine. A few minutes after the dose, she came back to say her throat felt a little swollen and itchy.  A dose of Diphenhydramine 50 mg was given right away.
Swelling of left thigh. Started within hours, post vax. Mild erythema, also. Entire thigh swollen to circumference of 3cm > than on opposite thight, when seen on 3rd day.
syringe malfunctioned during injection, internal spring was released too fast and some of the vaccine spilled out
Headache, Myalgia, Arthralgia, NauseaVomiting, chills, fatigue Narrative:
Diagnosed with Bell's Palsy. Complete loss of motor skills and movement on left side of face. Unable to close left eye, unable to raise left eye brow,  zero lip movement. Overall, total loss of control over lower cranial facial nerve. Prescribed with anti-viral and steroid. Recovery at about 95% of movement on August 9th, 2021.
Patient complained of tightness in throat, tingling on tongue, difficulty  breathing approximately 32min after receiving injection. Given epipen x1, still complained of symptoms 12min later, she was given a 2nd epi pen and transferred by EMS to a ER.
Patient presented to the ED on 4/1/2021 and diagnosed with COVID. She presented to the ED again on 4/3/2021 and was subsequently hospitalized. These encounters were within 6 weeks of receiving COVID vaccination.
Pt reported local reaction at injection site 3-4 inches of redness 3 inches induration hot to touch at site.
First noticed a few vesicles on 12/27/2005.  Within 2 day period was covered with vesicular rash, mild temperature, elevation and nausea/vomiting.  No medical treatment given only home care by home health nurse.
gradual development and worsening of pain/tenderness in left elbow (region of the lateral epicondyle) and forearm starting a few days after the shot  Also developed pain in both knees.   It is now almost three weeks from the date of the vaccination and the lateral epicondylar pain in not abating. tenderness in elbow with grasping with left hand. Left arm is non-dominant.  No recent straining or repetitive use of the left arm.
Information has been received from a physician concerning a 46-year-old male with omental panniculitis, and no allergies, who on 10-SEP-2007 was vaccinated with a subcutaneous 0.5 milliter dose in the right arm of Varivax. Concomitant therapy included hyoscyamineSO4 (LEVBID) and prednisone, 10 milligrams daily for his omental panniculitis. On 10-SEP-2007, the patient experienced pain in the abdomen, which is a symptom of his autoimmune disease (omental panniculitis). The patient was experiencing rectal symptoms (unspecified) on the day of vaccination. The patient was seen in the doctor's office on 14-Sep-2007 and 17-Sep-2007. On 14-Sep-2007, prednisone dosage was increased to 30 milligrams daily. On an unspecified date, the patient was hospitalized for symptoms of his disease. Laboratory and diagnostic tests performed included white blood cell count and a chemistry panel. The reporter felt that worsening of omental panniculitis was not related to therapy with Varivax. The outcome is reported as not recovered. No product quality complaint was involved. The reporter considered omental panniculitis disabling. Additional information has been requested.
This case was reported by a pharmacist and described the occurrence of swelling of tongue in an adult subject of unspecified gender who was vaccinated with influenza virus vaccine (Fluarix) for prophylaxis. On an unspecified date in October 2006, on or before 26 October 2006, the subject received unspecified dose of Fluarix. On an unspecified date in October 2006, less than one month after vaccination with Fluarix, the subject experienced swelling of tongue and injection site irritation. The subject was seen at a physician's office. The subject was treated with oral diphenhydramine hydrochloride (Benadryl). At the time of initial reporting, 26 October 2006, the tongue swelling had resolved. The outcome of the injection site irritation was not reported.
The very day I starting itching along the jaw bone. The next day my hands started breaking out as well. The itching was very intense. It then spread all over my body even on my feet. I also had a slight headache was about a 3 on a 1-10 pain scale. I am still breaking out but not as bad. The doctor gave me prednisone and a steroid cream.
Fever (days 1, 2, Tylenol); Spotty rash all over body except neck and face/head (day5 and still has it).
Patient was 11 years and 2 months old at the time of the visit and was given the pfizer covid -19 vaccination for patients that were over the age of 12.  Patient did not have any adverse reaction that we are aware of
Pfizer 5-11 formulation administered to person age 12 through 17 years